CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-27 | Nichols Christian Todd SVP, Chief Commercial Officer | Sale 10b5-1 | −5,208 | $29.15 | $152K | 60,703 |
| 2024-11-11 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise 10b5-1 | +43,058 | $20.03 | $862K | 142,296 |
| 2024-11-11 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale 10b5-1 | −58,996 | $30.08 | $1.8M | 83,300 |
| 2024-11-11 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −43,058 | 129,174 | ||
| 2024-11-06 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sale 10b5-1 | −10,471 | $29.53 | $309K | 99,238 |
| 2024-08-03 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +2,014 | 166,796 | ||
| 2024-08-03 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −895 | $27.72 | $25K | 165,901 |
| 2024-08-03 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −2,014 | 4,029 | ||
| 2024-06-29 | Wright Christopher I Director | Option exercise | +6,104 | 15,881 | ||
| 2024-06-29 | Wright Christopher I Director | Shares withheld for taxes | −1,465 | $24.10 | $35K | 14,416 |
| 2024-06-29 | Wright Christopher I Director | Option exercise · Restricted Stock Unit Award | −6,104 | 0 | ||
| 2024-06-29 | Wilson Frank Anders Director | Option exercise | +6,104 | 26,460 | ||
| 2024-06-29 | Wilson Frank Anders Director | Shares withheld for taxes | −1,465 | $24.10 | $35K | 24,995 |
| 2024-06-29 | Wilson Frank Anders Director | Option exercise · Restricted Stock Unit Award | −6,104 | 0 | ||
| 2024-06-29 | snyderman nancy lynn MD Director | Option exercise | +6,104 | 6,104 | ||
| 2024-06-29 | snyderman nancy lynn MD Director | Shares withheld for taxes | −1,465 | $24.10 | $35K | 4,639 |
| 2024-06-29 | snyderman nancy lynn MD Director | Option exercise · Restricted Stock Unit Award | −6,104 | 0 | ||
| 2024-06-29 | MCKEON BRIAN P Director | Option exercise | +6,104 | 29,245 | ||
| 2024-06-29 | MCKEON BRIAN P Director | Shares withheld for taxes | −1,465 | $24.10 | $35K | 27,780 |
| 2024-06-29 | MCKEON BRIAN P Director | Option exercise · Restricted Stock Unit Award | −6,104 | 0 |
Page 21 of 41 · 804 trades